The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Could Lipids Be a Key to Control Inflammation?

Could Lipids Be a Key to Control Inflammation?

March 18, 2011 • By Gretchen Henkel

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Animals were divided into four groups. Rats in the control group were given IV saline injections at the acute and chronic phases. The other three groups of animals received IV injections of apoA-1 (the main apolipoprotein in HDL) either alone or in combination with saline at different time periods: a single treatment during either the acute or chronic phases of inflammation, or, as in group 4, injections of only apoA-1 during both the acute and chronic phases. Regardless of when the apoA-1 was administered, the injection produced a markedly reduced inflammatory response. The team also looked at T-cell and monocyte activation in all groups of animals. They found that, irrespective of the timing of the apoA-1 injection, the T-cell and monocyte counts were reduced nearly to baseline levels by the end of the experimental period (21 days from injection of PG-PS).

You Might Also Like
  • Researchers Work to Untangle the Relationship Between Blood Lipids, Bone Health & Diet
  • Aggregated Neutrophils Limit Inflammation
  • Cholesterol Levels in Patients with RA Starting Methotrexate
Explore This Issue
March 2011
Also By This Author
  • Glimpse the Future

From these preliminary results, the team concluded that apoA-1 inhibits PG-PS–induced T-cell activation and cytokine production, and that it is effective in inhibiting joint inflammation in the Lewis rat. This study is part of an ongoing project, Dr. Rye noted, and her team has retained plasma and tissue samples from the animals to further test the levels of a list of chemokines to see whether the results hold. “We’re going to be looking much more closely at these markers and see if we can identify some of the pathways that are involved in mediating these effects,” she said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Linking Cholesterol Transport and Inflammation

Uwe J. F. Tietge, MD, PhD, professor of pediatrics at the Center for Liver, Digestive, and Metabolic Diseases at the University Medical Center Groningen, The Netherlands, also spoke at the session. In his talk entitled, “Liver X Receptor Signaling at the Crossroads between Immunity and Cholesterol Homeostasis,” Dr. Tietge first summarized the large body of work on reverse cholesterol transport (RCT), a process mediated by LXR transcription. Liver X receptors (LXRs) function as nuclear cholesterol sensors that are activated in response to elevated intracellular cholesterol levels in multiple cell types.2 When LXRs are activated, they induce expression of an array of genes involved in cholesterol absorption, efflux, transport, and excretion. “Globally,” noted Dr. Tietge, “LXR activation coordinates the response to eliminate cholesterol from the body.” LXRα, the alpha isoform, is mainly expressed in the liver, intestine, kidney, adrenals, adipose tissue, and macrophages. The beta isoform of LXR (LXRβ) is more ubiquitously expressed.

LXR activation also increases the expression of antiinflammatory genes. The ability of LXRs to integrate metabolic and inflammatory signaling makes them potentially attractive targets for designing interventions in metabolic disease.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: Cardiovascular disease, cholesterol, high-density lipoprotein, inflammation, Lipid, Rheumatoid arthritisIssue: March 2011

You Might Also Like:
  • Researchers Work to Untangle the Relationship Between Blood Lipids, Bone Health & Diet
  • Aggregated Neutrophils Limit Inflammation
  • Cholesterol Levels in Patients with RA Starting Methotrexate
  • Cardiovascular Disease Risk High in RA Patients

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.